Skip to main content
Livermore
Livermore
ZHEN

Capital Advantage, Inc.

SEC CIK
0001628896
Latest filing
Jul 13, 2026

The latest 13F from Capital Advantage, Inc. covers Q2 2026 (filed Jul 13, 2026): 150 long positions worth $819.6M. The top 10 holdings make up 51.4% of the portfolio, and the largest is Capital Grp Fixed Incm ETF T at 12.6%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
16
Est. +$44.1M
Added
45
Est. +$46.7M
Reduced
73
Est. −$91.5M
Sold out
11
Est. −$11.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. Capital Grp Fixed Incm ETF T14020Y300
    12.6%$103.6M
  2. Schwab Fundamental International Equity ETF808524755
    7.1%$58.1M
  3. Vanguard Whitehall FDS921946794
    5.0%$40.8M
  4. Vanguard Whitehall FDS921946810
    4.9%$40.3M
  5. iShares Tr46434V878
    4.6%$37.6M

Biggest buys

New and added positions, by estimated amount bought

  1. Capital Grp Fixed Incm ETF T14020Y300
    +$35.3MAdded
  2. iShares Tr46429B747
    +$26.4MNew
  3. iShares Tr46434V860
    +$13.7MNew
  4. Vanguard BD Index FDS92203C303
    +$3.21MAdded
  5. Schwab Fundamental U.S. Large Company ETF808524771
    +$1.09MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Capital Grp Fixed Incm ETF T14020Y300
    +3.75 pp8.9% → 12.6%
  2. iShares Tr46429B747
    +3.23 pp0.0% → 3.2%
  3. iShares Tr46434V860
    +1.67 pp0.0% → 1.7%
  4. Capital Group Dividend Value14020W106
    +0.26 pp3.0% → 3.2%
  5. State Street SPDR Portfolio S&P 500 ETF78464A854
    +0.25 pp2.4% → 2.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Vanguard Intermediate-Term Corporate Bond ETF92206C870
    −$79.9MReduced
  2. TWLOTwilio Inc
    −$5.85MSold outHistory
  3. AMDAdvanced Micro Devices Inc
    −$3.36MReducedHistory
  4. XOMExxonMobil Holdings Corp
    −$2.45MSold outHistory
  5. CSCOCisco Systems, Inc.
    −$1.55MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Vanguard Intermediate-Term Corporate Bond ETF92206C870
    −10.46 pp10.5% → 0.1%
  2. TWLOTwilio Inc
    −0.76 pp0.8% → 0.0%History
  3. XOMExxonMobil Holdings Corp
    −0.32 pp0.3% → 0.0%History
  4. CVXChevron Corp
    −0.15 pp0.5% → 0.4%History
  5. Vanguard Whitehall FDS921946810
    −0.12 pp5.0% → 4.9%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$819.6M
+$54.7M (+7.1%) vs. prior quarter
Positions
150
+5 vs. prior quarter
Top 10 concentration
51.4%
Top 10 as share of value
Turnover
11.5%
Q2 2026, one quarter
Average holding period
13.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $819.6M (Q2 2026)

Q1 2021: $366.9MQ2 2021: $381.5MQ3 2021: $370.2MQ4 2021: $417.3MQ1 2022: $434.8MQ2 2022: $453.7MQ3 2022: $437.0MQ4 2022: $445.4MQ1 2023: $470.0MQ2 2023: $479.5MQ3 2023: $466.5MQ4 2023: $492.8MQ1 2024: $492.5MQ2 2024: $487.9MQ3 2024: $521.9MQ4 2024: $548.8MQ1 2025: $548.8MQ2 2025: $631.4MQ3 2025: $665.0MQ4 2025: $741.3MQ1 2026: $765.0MQ2 2026: $819.6M
Q1 2021Q2 2026
13F filings of Capital Advantage, Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 13, 2026150$819.6MCapital Grp Fixed Incm ETF TSchwab Fundamental International Equity ETFVanguard Whitehall FDSvs. Q1 2026SEC
Q1 2026Apr 13, 2026145$765.0MVanguard Intermediate-Term Corporate Bond ETFCapital Grp Fixed Incm ETF TSchwab Fundamental International Equity ETFvs. Q4 2025SEC
Q4 2025Jan 7, 2026149$741.3MVanguard Intermediate-Term Corporate Bond ETFCapital Grp Fixed Incm ETF TSchwab Fundamental International Equity ETFvs. Q3 2025SEC
Q3 2025Oct 22, 2025138$665.0MVanguard Intermediate-Term Corporate Bond ETFCapital Grp Fixed Incm ETF TSchwab Fundamental International Equity ETFvs. Q2 2025SEC
Q2 2025Jul 11, 2025139$631.4MVanguard Intermediate-Term Corporate Bond ETFCapital Grp Fixed Incm ETF TSchwab Fundamental International Equity ETFvs. Q1 2025SEC
Q1 2025Apr 10, 2025135$548.8MVanguard Intermediate-Term Corporate Bond ETFSchwab Fundamental International Equity ETFVanguard Whitehall FDSvs. Q4 2024SEC
Q4 2024Feb 14, 2025135$548.8MVanguard Intermediate-Term Corporate Bond ETFSchwab Fundamental International Equity ETFVanguard Whitehall FDSvs. Q3 2024SEC
Q3 2024Nov 7, 202449$521.9MVanguard Intermediate-Term Corporate Bond ETFSchwab Fundamental International Equity ETFVanguard Whitehall FDSvs. Q2 2024SEC
Q2 2024Jul 12, 202448$487.9MVanguard Intermediate-Term Corporate Bond ETFSchwab Fundamental International Equity ETFiShares Trvs. Q1 2024SEC
Q1 2024May 14, 202448$492.5MVanguard Intermediate-Term Corporate Bond ETFiShares TrProShares Trvs. Q4 2023SEC
Q4 2023Jan 23, 202440$492.8MVanguard Intermediate-Term Corporate Bond ETFProShares TriShares Trvs. Q3 2023SEC
Q3 2023Oct 30, 202342$466.5MProShares TrVanguard Intermediate-Term Corporate Bond ETFiShares Trvs. Q2 2023SEC
Q2 2023Aug 7, 202343$479.5MProShares TrVanguard Intermediate-Term Corporate Bond ETFiShares Trvs. Q1 2023SEC
Q1 2023May 5, 202340$470.0MProShares TriShares TrVanguard Intermediate-Term Corporate Bond ETFvs. Q4 2022SEC
Q4 2022Jan 24, 202338$445.4MProShares TriShares TriShares Trvs. Q3 2022SEC
Q3 2022Oct 31, 202241$437.0MiShares TrProShares TriShares Trvs. Q2 2022SEC
Q2 2022Jul 21, 202243$453.7MProShares TriShares TriShares Trvs. Q1 2022SEC
Q1 2022May 10, 202243$434.8MProShares TrVanguard Whitehall FDSVanguard Health Care ETFvs. Q4 2021SEC
Q4 2021Jan 21, 202248$417.3MProShares TrVanguard Whitehall FDSVanguard Health Care ETFvs. Q3 2021SEC
Q3 2021Oct 7, 202146$370.2MProShares TrVanguard Whitehall FDSVanguard Health Care ETFvs. Q2 2021SEC
Q2 2021Aug 16, 202146$381.5MProShares TrVanguard Whitehall FDSVanguard Dividend Appreciation ETFvs. Q1 2021SEC
Q1 2021Apr 26, 2021107$366.9MVanguard Whitehall FDSVanguard Dividend Appreciation ETFVanguard Health Care ETF–SEC